German China

USA: Biopharmaceutical Characterization and Monitoring Methods

Thermo Fisher Scientific to Collaborate with Genovis

| Editor: Alexander Stark

Thermo Scientific Vanquish Duo UHPLC Systems
Gallery: 1 image
Thermo Scientific Vanquish Duo UHPLC Systems (Source: Thermo Fisher Scientific)

Thermo Fisher Scientific and Genovis, a provider of enzyme products for biological drug development, announced a collaborative research project. The aim of the collaboration is to develop advanced end-to-end workflows for the preparation, characterization and monitoring of novel and complex biotherapeutics using liquid chromatography-mass spectrometry (LC-MS).

Sunnyvale/USA — Bringing together Thermo Fisher’s LC-MS technology with the advanced enzyme-based sample preparation and analysis techniques of Genovis is to enable the development of robust, automation-ready, magnetic bead and chromatography-based workflows for the streamlined analysis of biotherapeutics. Expertise from Thermo Fisher’s Global Customer Solution Centers will also help the partner to determine optimal hardware/software configurations and suitable consumables for critical quality attribute (CQA) analysis of biotherapeutics during the research and development phase.

By collaborating with Genovis, the company plans to develop comprehensive workflows that provide robust and advanced solutions for preparing and assessing complex biotherapeutics. The combination of the Thermo Scientific Vanquish Duo UHPLC Systems (with Dual LC workflow) and the Thermo Scientific Chromeleon Chromatography Data System (CDS) Software with the SmartEnzyme technology from Genovis will enable the development of LC-MS-based protocols for O-glycosylation profiling and automated high-throughput workflows for CQA analysis of monoclonal antibodies at the subunit level.

Symphogen to Use Thermo Fisher's Mass Spectrometry Technology to Analyze Complex Therapeutic Proteins

USA: New Therapies for Cancer Patients

Symphogen to Use Thermo Fisher's Mass Spectrometry Technology to Analyze Complex Therapeutic Proteins

12/11/2018 - Thermo Fisher Scientific and Symphogen, a clinical-stage antibody oncology-focused company, have entered into a two-year collaborative partnership to deliver validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins. read...

Comments are being loaded ....

Leave a comment

The comment is checked by an editor and will be released soon.

  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 45858920 / Laborpraxis Worldwide)